Immunomic Therapeutics
Yun-Ting Kao is a multifaceted research scientist with experience in vaccine research, plant biology, and biochemistry. They have held positions at various prestigious institutions, overseeing lab management, conducting research on plant signaling transduction, and organizing research symposiums. With a Ph.D. in Biochemistry and Cell Biology, Yun-Ting has a strong background in biological research and enhancing science literacy through education.
Immunomic Therapeutics
1 followers
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.